Evaluation of the tetracycline-repressible transactivator system for inducible gene expression in human prostate cancer cell lines

Prostate

Volumn 33, Issue 3, 1997, Pages 166-176

  Gschwend, Jürgen E ^a   Fair, William R ^a   Powell, C Thomas ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Death genes; LNCaP; PC 3; Tsu Pr1

Indexed keywords

LUCIFERASE; RNA; TETRACYCLINE REPRESSIBLE TRANSACTIVATOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REPRESSOR GENE; RNA ANALYSIS;

CELL LINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MALE; PLASMIDS; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; TETRACYCLINE; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030684083     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19971101)33:3<166::AID-PROS4>3.0.CO;2-H     Document Type: Article

References (25)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer Statistics 1996: CA 1996;46:5-27.
2. Eastham JA, Hall SJ, Sehgal I, Wang J, Timme TL, Yang G, Connell-Crowley L, Elledge SJ, Zhang WW, Harper JW: In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res 1995;55:5151-5155.
3. Rosenfeld MR, Meneses P, Dalmau J, Drobnjak M, Cordon-Cardo C, Kaplitt MG: Gene transfer of wild-type p53 results in restoration of tumor-suppressor function in a medulloblastoma cell line. Neurology 1995;45:1533-1538.
4. Yang C, Corrado C, Capogrossi MC, Passaniti A: Adenovirusmediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res 1995;55:4210-4213.
5. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992;89:5547-5551.
6. Gossen M, Bonin AL, Bujard H: Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. TIBS 1993;18:471-475.
7. Wimmel A, Lucibello FC, Sewing A, Adolph S, Müller R: Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 1994;9:995-997.
8. Resnitzky D, Gossen M, Bujard H, Reed SI: Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994;14:1669-1679.
9. Efrat S, Fusco-DeMane D, Lemberg H, Emran OA, Wang X: Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA 1995;92:3576-3580.
10. Howe JR, Skryabin BV, Belcher SM, Zerillo CA, Schmauss C: The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem 1995;270:14168-14174.
11. Furth PA, Onge LS, Böger H, Gruss P, Gossen M, Kistner A, Bujard H, Henninghausen L: Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994;91:9302-9306.
12. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP: LNCaP model of human prostatic cancer. Cancer Res 1983;43:1809-1818.
13. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17:16-20.
14. Iizumi T, Yazaki T, Kanoh S, Kondo I, Koiso K: Establishment of a new prostatic carcinoma cell line (Tsu-Pr1). J Urol 1987;137:1304-1306.
15. Sambrook J, Fritsch EF, Maniatis T: "Molecular Cloning - A Laboratory Manual," 2nd ed. Cold Spring Harbor Laboratory Press, 1989.
16. te Riele H, Maandag ER, Clarke A, Hooper M, Berns A: Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature 1990;348:649-651.
17. Bradford M: A rapid and sensitive method for protein quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-254.
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
19. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing bacteriophage SP6 promoter. Nucleic Acids Res 1984;12:7035-7056.
20. Laborda J: 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 1991;19:3998-4001.
21. Powell CT, Brittis NJ, Stec D, Hug H, Heston WDW, Fair WR: Persistent membrane translocation of protein kinase C α during 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ 1996;7:419-428.
22. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H: Transcriptional activation by tetracyclines in mammalian cells. Science 1995;268:1766-1769.
23. Kavallaris M, Madafiglio J, Norris MD, Haber M: Resistance to tetracycline, a hydrophilic antibiotic, is mediated by p-glycoprotein in human multidrug-resistant cells. Biochem Biophys Res Commun 1993;190:79-85.
24. Theyer G, Schirmböck M, Thalhammer T, Sherwood ER, Baumgartner G, Hamilton G: Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines. J Urol 1993;150:1544-1547.
25. Gossen M: Prokaryontische Repressor/Operatorsysteme in der Kontrolle der eukaryontischen Genexpression. Dissertation. Heidelberg: Heidelberg University, 1993.